Last reviewed · How we verify
NCT04839081
Neuropathic Hand Pain in Rheumatoid Arthritis
trial testing questionnaires and inventories in Rheumatoid Arthritis in 300 participants. Participants enrolled and being followed up; not accepting new ones.
15 May 2025
Quick facts
| Lead sponsor | Bozyaka Training and Research Hospital |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 26 April 2021 |
| Primary completion | 15 May 2025 |
| Estimated completion | 15 June 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- questionnaires and inventories
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Sponsor
Bozyaka Training and Research Hospital
Who can join
Adults 18 to 70, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators have aimed to estimate prevalence of neuropathic hand pain in RA patients and it's relation with sleep quality and sensory thresholds. For this purpose a case-control study design was planned. Age- and sex-matched control subjects will be chosen among individuals submitted to out-patient clinic with the complaint of nociceptive/mechanical pain other than in hand, lasting more than three months
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04839081
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of questionnaires and inventories
Trials testing the same drug.
- NCT05096767 — Neuropathic Spinal Pain Descriptors in Ankylosing Spondylitis · recruiting
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Bozyaka Training and Research Hospital trials
Trials by the same sponsor.
- NCT06996977 — Menstrual Cycle and Postanesthetic Shivering · not yet recruiting
- NCT06984653 — Effect of Scalp Block on Bispectral Index Values During Skull Pinning · completed
- NCT06759506 — Can Perfusion Index and Cerebral Oxygen Saturation Trends Predict Low Cardiac Output in Pediatric Cardiovascular Surgeri · not yet recruiting
- NCT06430918 — Neuropathic Pain and it's Relation to Sleep Quality in Knee Osteoarthritis · enrolling by invitation
- NCT06029413 — Myo vs. Myofascial Injection for Myofascial Trigger Points · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04839081 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bozyaka Training and Research Hospital
- Last refreshed: 21 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04839081.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing